With COVID-19 affecting the globe for well over a year at this point, many researchers have shifted their focus to the virus. While there are many COVID-19 related questions still needing answers, it is incredible what the scientific community has achieved in such a short period of time.

Our reagents have been used by customers in a handful of publications that have helped us learn more about the virus. We've just added a new page to our website to compile all these publications. Visit it here.

Image: Detected auto Ig levels in specific cell types, including our human small intestine endothelial cells.

Included is a publication from researchers at Emory University comparing the plasma of COVID-19 patients to healthy patients to study the pathogenesis of severe COVID-19. In this research, they used our Human Small Intestine Endothelial Cells (cat.# HEC15). Check out this blog post to learn more.

A second publication utilizes our Human Brain Microvascular Endothelial Cells (cat.# HEC02) to find a microRNA capable of targeting Neuropilin-1, a transmembrane glycoprotein that plays a role in the cellular entry of the SARs-CoV-2 virus. Learn more.

Neuromics' continues to grow our selection of products that have applications in COVID-19 research. In case you missed it, we just added six recombinantly expressed MHC class I molecules that present a peptide from the SARS-CoV-2 virus. Additionally, we recently generated data demonstrating our 3D Human Blood-Brain Barrier Model (cat.# 3D45002) expresses the ACE-2 receptor, the protein that the COVID-19 virus binds to.

You can view all of our COVID-19 related research reagents here.